Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (19 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 21 Oct 2020 – 20 Aug 2026, limited by SBI Nifty IT ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | SBI Nifty IT ETF | Nifty 500 |
|---|---|---|
| 21 Oct 2020 | ₹100.00 | ₹100.00 |
| 16 Apr 2021 | ₹122.80 | ₹126.05 |
| 11 Oct 2021 | ₹165.67 | ₹158.13 |
| 06 Apr 2022 | ₹169.94 | ₹157.10 |
| 01 Oct 2022 | ₹129.28 | ₹151.99 |
| 27 Mar 2023 | ₹134.79 | ₹146.19 |
| 21 Sep 2023 | ₹160.05 | ₹177.35 |
| 16 Mar 2024 | ₹183.84 | ₹203.20 |
| 09 Sep 2024 | ₹207.42 | ₹240.88 |
| 06 Mar 2025 | ₹190.65 | ₹209.57 |
| 30 Aug 2025 | ₹177.58 | ₹230.23 |
| 24 Feb 2026 | ₹153.50 | ₹238.86 |
| 20 Aug 2026 | ₹157.78 | ₹241.00 |
| Metric | SBI · Regular · IDCW NAV ₹340.36 Very High risk ★☆☆☆☆ | Category median Other ETFs · 19 funds |
|---|---|---|
| -12.42% | +0.77% | |
| +1.96% | +9.55% | |
| +0.11% | +9.21% | |
| — | +11.55% | |
| +8.14% | +10.84% | |
| -1.50% | — | |
| +8.74% | +13.03% | |
| +6.01% | +13.13% | |
| — | +12.79% | |
| Risk | ||
| 21.95% | 13.68% | |
| -0.21 | 0.22 | |
| -0.29 | 0.31 | |
| -42.17% | -21.96% | |
| Nifty 500 | — | |
| -6.33% | +0.04% | |
| 0.76 | 0.99 | |
| 40.9% | 99.9% | |
| 63.5% | 95.5% | |
| 0.26% | 0.25% | |
| ₹71.10Cr | ₹77.96Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Harsh Sethi | — | |
| 21 Oct 2020 | — | |
| 10 | — | |
| 99.9% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.